JP2002509144A5 - - Google Patents

Download PDF

Info

Publication number
JP2002509144A5
JP2002509144A5 JP2000540132A JP2000540132A JP2002509144A5 JP 2002509144 A5 JP2002509144 A5 JP 2002509144A5 JP 2000540132 A JP2000540132 A JP 2000540132A JP 2000540132 A JP2000540132 A JP 2000540132A JP 2002509144 A5 JP2002509144 A5 JP 2002509144A5
Authority
JP
Japan
Prior art keywords
group
alkyl
formula
same
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000540132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002509144A (ja
Filing date
Publication date
Priority claimed from DE19801646A external-priority patent/DE19801646A1/de
Application filed filed Critical
Publication of JP2002509144A publication Critical patent/JP2002509144A/ja
Publication of JP2002509144A5 publication Critical patent/JP2002509144A5/ja
Pending legal-status Critical Current

Links

JP2000540132A 1998-01-17 1999-01-12 置換α,β−縮合ブチロラクトン Pending JP2002509144A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19801646A DE19801646A1 (de) 1998-01-17 1998-01-17 Substituierte alpha,beta-annellierte Butyrolactone
DE19801646.8 1998-01-17
PCT/EP1999/000132 WO1999036416A1 (de) 1998-01-17 1999-01-12 SUBSTITUIERTE α,β-ANELLIERTE BUTYROLACTONE

Publications (2)

Publication Number Publication Date
JP2002509144A JP2002509144A (ja) 2002-03-26
JP2002509144A5 true JP2002509144A5 (cg-RX-API-DMAC10.html) 2006-02-23

Family

ID=7854912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000540132A Pending JP2002509144A (ja) 1998-01-17 1999-01-12 置換α,β−縮合ブチロラクトン

Country Status (7)

Country Link
US (2) US6462074B1 (cg-RX-API-DMAC10.html)
EP (1) EP1047684B1 (cg-RX-API-DMAC10.html)
JP (1) JP2002509144A (cg-RX-API-DMAC10.html)
AU (1) AU2517299A (cg-RX-API-DMAC10.html)
DE (2) DE19801646A1 (cg-RX-API-DMAC10.html)
ES (1) ES2185316T3 (cg-RX-API-DMAC10.html)
WO (1) WO1999036416A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932621A1 (de) * 1999-07-13 2001-04-26 Bayer Ag Neue substituerte alpha, beta-anellierte Butyrolactone
WO2005037286A1 (en) * 2003-03-25 2005-04-28 Vasopharm Biotech Gmbh Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
US7311701B2 (en) * 2003-06-10 2007-12-25 Cierra, Inc. Methods and apparatus for non-invasively treating atrial fibrillation using high intensity focused ultrasound
CN101094835B (zh) * 2004-11-03 2011-07-27 弗·哈夫曼-拉罗切有限公司 二酰胺衍生物
GB0713686D0 (en) 2007-07-13 2007-08-22 Addex Pharmaceuticals Sa New compounds 2
AR078171A1 (es) * 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN116570594A (zh) 2016-06-23 2023-08-11 马里兰大学巴尔的摩分校 选择性p38α特异性MAPK抑制剂
JP7594787B2 (ja) 2018-12-07 2024-12-05 ユニバーシティ オブ メリーランド、ボルチモア 非ATP/触媒部位p38マイトジェン活性化プロテインキナーゼ阻害剤
CN116406355B (zh) 2020-05-18 2026-05-15 Gen1E生命科学公司 P38α促分裂原活化蛋白激酶抑制剂
AU2021370893B2 (en) 2020-10-29 2024-03-07 Gen1E Lifesciences Inc. Crystalline 5-(dimethylamino) -n- (4-(morpholinomethyl)phenyl) naphthalene-1-sulfonamide di-hydrochloride di-hydrate
NZ804686A (en) 2021-03-23 2026-03-27 Gen1E Lifesciences Inc Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2605630B1 (fr) * 1986-10-22 1989-06-30 Roussel Uclaf Procede de preparation de derives de l'octahydroindole et intermediaires de preparation
NZ240921A (en) 1990-12-12 1994-06-27 Zymogenetics Inc G protein coupled glutamate receptor (neurotransmitters), recombinant production
US5576323A (en) 1993-12-03 1996-11-19 Eli Lilly And Company Excitatory amino acid receptor antagonists
FR2713064B1 (fr) 1993-12-03 1996-01-12 Fantino Gilles Siège dont le dossier articulé fait office de couverture de protection pour l'assise lorsqu'il est rabattu.
GB9324872D0 (en) 1993-12-03 1994-01-19 Univ Pasteur Pharmaceutical compounds
GB9325368D0 (en) 1993-12-10 1994-02-16 Univ Bristol Organic compounds
GB9325360D0 (en) 1993-12-10 1994-02-16 Univ Bristol Organic compounds
CZ265096A3 (en) 1994-03-14 1997-06-11 Novo Nordisk As Thienoindole derivatives, their use, process of their preparation and pharmaceutical composition containing thereof
AU3414295A (en) 1994-08-19 1996-03-14 Nps Pharmaceuticals, Inc. Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases
EP0771196B1 (en) * 1994-09-08 1999-12-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5717109A (en) 1994-09-08 1998-02-10 Eli Lilly And Company Excitatory amino acid receptor antagonists
JP3993651B2 (ja) 1994-10-21 2007-10-17 アスビオファーマ株式会社 シクロプロパクロメンカルボン酸誘導体
AU1106195A (en) 1994-11-09 1996-06-06 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
US5701168A (en) 1995-06-29 1997-12-23 Bell Communications Research, Inc. Inverse twisted and super-twisted nematic liquid crystal device
AU6514196A (en) 1995-07-31 1997-02-26 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
WO1997005109A1 (en) 1995-07-31 1997-02-13 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
GB9605429D0 (en) 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5688826A (en) 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
EA001617B1 (ru) * 1995-11-16 2001-06-25 Эли Лилли Энд Компани Антагонисты рецепторов возбудительной аминокислоты

Similar Documents

Publication Publication Date Title
JP2002523396A5 (cg-RX-API-DMAC10.html)
RU2001108591A (ru) Арилпиперазины и их применение в качестве агентов-ингибиторов металлопротеиназ (ммр)
US4260769A (en) 5,5-Diphenylhydantoins
JPH04982B2 (cg-RX-API-DMAC10.html)
CA2344290A1 (en) Quinazoline derivatives
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
KR850008170A (ko) 피롤로 벤즈 이미다졸의 제조방법과 그들 함유의 약학적 조성물
RU2000103491A (ru) Конденсированные производные 1,2,4-тиадиазина, их получение и применение.
EP0539509B1 (en) 4-alkylimidazole derivatives
RU2004130488A (ru) Пиримидиновые производные
IE38886L (en) Quinoline-3-carboxamidotetrazole derivatives
FI94527B (fi) Analogiamenetelmä lääkeaineena käyttökelpoisen bifenyyli-imidatsopyridiinijohdannaisen valmistamiseksi
ATE448226T1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
KR900011739A (ko) β-차단/안기 오텐신 Ⅱ 차단 혈압강하제 혼합물
ATE311358T1 (de) Immunoregulierende verbindungen, deren derivate und ihre verwendung
CA2336412A1 (en) Medicament for treatment of diabetes
US4163058A (en) Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
EP1857442A3 (en) Novel antimycobacterial compounds
HUT56343A (en) Process for producing 3-aminopyrrol derivatives and pahrmaceutical compositions comprising same
KR960701029A (ko) 하이드록시메틸 푸라잔 카복실산 유도체 및 심장 혈관 질환 치료에서의 이의 용도(Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions)
EP1664055A1 (fr) Derives de 9-amino-podophyllotoxine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1254907A4 (en) Pyrrolopyridazine CONNECTIONS
KR900001701A (ko) 이미다조피라졸 유도체의 진통제 및 항염제로서의 용도
WO2002018344A1 (en) Novel ester or amide derivatives
KR0147832B1 (ko) 간질 치료용 피라졸로피리딘